Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Gregory Kaltsas

Professor General Medicine - Endocrinology

National and Kapodistrian University of Athens - Faculty of Medicine

Greece

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Internal Medicine

30%

Pharmacology

30%

Endocrinology

50%

Cancer Biology

50%

Neuroendocrine Tumor

50%

Tyrosine Kinase

20%

Thyroid Cancer

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Inherited/Genetically-Associated Pheochromocytoma/ Paraganglioma Syndromes and COVID-19

Article Link

Year:

2021

Clinical Utility of <sup>18</sup>F-FDG PET in Neuroendocrine Tumors Prior to Peptide Receptor Radionuclide Therapy: A Systematic Review and Meta-Analysis

Article Link

Year:

2021

A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood

Article Link

Year:

2020

A prolapsing pituitary adenoma

Article Link

Year:

2020

Endocrinological Toxicity Secondary to Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)

Article Link

Year:

2020

Erratum: Anti-Tumor Activity and Safety of Multikinase Inhibitors in Advanced and/or Metastatic Thyroid Cancer: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials (Hormone and Metabolic Research DOI: 10.1055/a-1023-4214)

Article Link

Year:

2020

Expression of clock-related genes in benign and malignant adrenal tumors

Article Link

Year:

2020

Increased autophagy/mitophagy levels in primary tumours of patients with pancreatic neuroendocrine neoplasms

Article Link

Year:

2020

Anti-Tumor Activity and Safety of Multikinase Inhibitors in Advanced and/or Metastatic Thyroid Cancer: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Article Link

Year:

2020

Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms"

Article Link

Year:

2020

Collaborators2

Maria-Eleni Spei

National and Kapodistrian University of Athens

GREECE

Simona Grozinsky-Glasberg

ISRAEL

How do I reach out?

Meet Kite AI